John Fair joined Daré Bioscience, Inc. in 2018 and currently serves as Chief Strategy Officer where he is responsible for licensing, acquisitions, strategic partnering and corporate strategy. John was previously Managing Director of Capital F Consulting, a privately held consulting firm focused on healthcare consulting, capital raising and investor communications. From 2012 to 2016, John held senior-level executive roles, including President and COO, of a privately held specialty healthcare company developing products for women’s health, microbiome and infectious disease. In that role, John was responsible for commercial strategy, operations and product development. Previously, John served in a number of executive level roles for specialty healthcare and venture-backed healthcare service businesses and was instrumental in building companies and capabilities that led to successful M&A exits. John has broad therapeutic experience that includes oncology, hematology, virology and women’s health and he began his career as a portfolio strategy and insights consultant supporting numerous brands and franchises in the pharmaceutical, OTC and consumer healthcare markets. John holds a master’s degree from the University of Pennsylvania, Perelman School of Medicine and a bachelor’s degree from Rider University. He has completed executive education in corporate strategy, mergers and acquisitions at Stanford University Graduate School of Business.